Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens

E-ISSN： 1875-533x|22|14|1719-1733

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.14, 2015-05, pp. : 1719-1733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New partnership to develop an HIV vaccine for India

Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Potential of Polyphosphazenes for Delivery of Vaccine Antigens and Immunotherapeutic Agents

Current Drug Delivery, Vol. 7, Iss. 1, 2010-01 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite

Defining Carbohydrate Antigens as HIV Vaccine Candidates

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 185-201

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic determinants of virulence in the group B coxsackieviruses

By Kim Kisoon Kanno Toru Chapman Nora M Tracy Steven

Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. : 597-604

Future Medicine

Access to resources Recommend Favorite

Molecular Determinants of the Cardiometabolic Phenotype

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 2, 2010-06 ,pp. : 109-123

Bentham Science Publishers

Access to resources Recommend Favorite